Marimed (MRMD) Current Deferred Revenue (2011 - 2026)

Marimed (MRMD) has 12 years of Current Deferred Revenue data on file, last reported at $1.5 million in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (changed N/A YoY), and the FY2025 annual result was $1.4 million, up 4.89% from the prior year.
• Current Deferred Revenue rose to $1.5 million in Q1 2026 per MRMD's latest filing, from $1.4 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $1.7 million in Q3 2025 and troughed at $1.3 million in Q4 2024.
• A 3-year average of $1.5 million and a median of $1.4 million in 2025 frame the typical range for Current Deferred Revenue.
• On a YoY basis, Current Deferred Revenue climbed as much as 4.89% in 2025 and fell as far as 4.89% in 2025.
• A 3-year view of Current Deferred Revenue shows it stood at $1.3 million in 2024, then climbed by 4.89% to $1.4 million in 2025, then increased by 5.67% to $1.5 million in 2026.
• Business Quant data shows MRMD's Current Deferred Revenue at $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $1.7 million in Q3 2025.